HER2 is a highly alluring target antigen owing to its high abundance in brain tumors, its role in tumor progression, and the capacity of HER2-specific CAR T cells to eradicate both differentiated cells and cancer-initiating cells [96]. Here, ERBB2 is linked to neoplasm.